For Publishers
DiscoveryMetadataPeer reviewHostingPublishing
For Researchers
JoinPublishReviewCollect
Register
Blog
About
Search
Advanced search
My ScienceOpen
Search
For Publishers
For Researchers
Blog
About
15
views
1
references
 Top references
cited by
0
    
0 reviews
 Review
0
comments
 Comment
0
recommends
+1 Recommend
1 collections
    0
    shares
      161
      similar
       All similar
      Are you tired of sifting through news that doesn't interest you?
      Personalize your Karger newsletter today and get only the news that matters to you!

      Sign up

      • Record: found
      • Abstract: found
      • Article: found

      Sialoglycoconjugates in Primary and Recurrent Mixed Tumors of Lacrimal Glands

      case-report

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          We examined the activity of Griffonia simplicifolia II agglutinin (GS2) before and after neuraminidase treatment in 2 cases of primary benign mixed tumor (BMT) and a case of recurrent mixed tumor (MT). Histologically, each type of MT is comprised of epithelial and mesenchymal components. GS2, which showed no binding to either structural component in the primary BMT, was specifically bound to the mesenchymal component in the recurrent MT. After neuraminidase treatment, there was a marked increase in GS2-binding levels in the epithelial component of the primary BMT and in both components of the recurrent MT. These results might reveal a prominent sialylation in the recurrent MT.

          Related collections

          Most cited references1

          • Record: found
          • Abstract: found
          • Article: not found

          Metastatic potential of transformed rat 3Y1 cell lines is inversely correlated with lysosomal-type sialidase activity.

          K Hata, S Taniguchi, Katsufumi Sato … (1994)
          We have investigated sialidase activities in transformed rat 3Y1 cells of different metastatic potential. Only lysosome-type sialidase was apparent in the particulate fractions of 3Y1 cells and their transformants. As compared with control 3Y1 cells, src-transformed cells exhibited decreased sialidase activity, and v-fos transfer to these latter induced even more severe decrease in the sialidase activity with acquisition of high lung metastatic ability. Various lysosomal enzymes other than sialidase were hardly affected by the transformation. Sialic acid transfer to N-linked glycoproteins was slightly elevated in the transformants, but not in parallel with their metastatic potential.
          Article 0 comments Cited 7 times – based on 0 reviews     Review now
            Bookmark
            All references

            Author and article information

            Journal
            Journal ID (publisher-id): ORE
            Journal ID (nlm-ta): Ophthalmic Res
            Journal ID (doi): 10.1159/issn.0030-3747
            Title: Ophthalmic Research
            Publisher: S. Karger AG
            ISSN (Print): 0030-3747
            ISSN (Electronic): 1423-0259
            Publication date Subscription-year: 1998
            Publication date (Print): December 1998
            Publication date (Electronic): 05 October 1998
            Volume: 30
            Issue: 6
            Pages: 374-379
            Affiliations
            a Department of Ophthalmology, Akita University School of Medicine, and b Section of Ophthalmology, Nakadori General Hospital, Akita, Japan
            Article
            Publisher ID: 55498 Other ID: Ophthalmic Res 1998;30:374–379
            DOI: 10.1159/000055498
            PubMed ID: 9731119
            SO-VID: 67d32e73-0a2d-4d8e-82ba-ed47f6fe31d0
            Copyright © © 1998 S. Karger AG, Basel
            License:

            Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

            History
            Page count
            Figures: 2, Tables: 1, References: 18, Pages: 6
            Categories
            Subject: Original Paper

            ScienceOpen disciplines: Vision sciences,Ophthalmology & Optometry,Pathology
            Keywords: Lectin cytochemistry,Neuraminidase treatment,Sialic acid,Benign mixed tumor,Lacrimal gland,<italic>Griffonia simplicifolia </italic>II agglutinin
            Data availability:
            ScienceOpen disciplines: Vision sciences, Ophthalmology & Optometry, Pathology
            Keywords: Lectin cytochemistry, Neuraminidase treatment, Sialic acid, Benign mixed tumor, Lacrimal gland, <italic>Griffonia simplicifolia </italic>II agglutinin

            Comments

            Comment on this article